IFNG and neoplasm: As discussed earlier, the therapeutic efficacy of anticancer chemotherapies largely depends on DCs, which present antigens from dying cancer cells to prime tumor‐specific IFN‐γ‐producing T lymphocytes (Fig. 3) [43, 60].